Reduction in Disease Progression by Inhibition of Transforming Growth Factor α-CCL2 Signaling in Experimental Posttraumatic Osteoarthritis
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Reduction in Disease Progression by Inhibition of Transforming Growth Factor α-CCL2 Signaling in Experimental Posttraumatic Osteoarthritis
Authors
Keywords
-
Journal
Arthritis & Rheumatology
Volume 67, Issue 10, Pages 2691-2701
Publisher
Wiley
Online
2015-07-02
DOI
10.1002/art.39255
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cartilage-specific deletion of Mig-6 results in osteoarthritis-like disorder with excessive articular chondrocyte proliferation
- (2014) B. Staal et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Disturbed Cartilage and Joint Homeostasis Resulting From a Loss of Mitogen-Inducible Gene 6 in a Mouse Model of Joint Dysfunction
- (2014) Michael A. Pest et al. Arthritis & Rheumatology
- Monocyte chemotactic protein-1 inhibits chondrogenesis of synovial mesenchymal progenitor cells: An in vitro study
- (2013) Quinn Harris et al. STEM CELLS
- Transient anabolic effects accompany epidermal growth factor receptor signal activation in articular cartilage in vivo
- (2013) John B Shepard et al. ARTHRITIS RESEARCH & THERAPY
- Efficacy and safety of strontium ranelate in the treatment of knee osteoarthritis: results of a double-blind, randomised placebo-controlled trial
- (2012) Jean-Yves Reginster et al. ANNALS OF THE RHEUMATIC DISEASES
- A 2-year randomised, double-blind, placebo-controlled, multicentre study of oral selective iNOS inhibitor, cindunistat (SD-6010), in patients with symptomatic osteoarthritis of the knee
- (2012) Marie-Pierre Hellio le Graverand et al. ANNALS OF THE RHEUMATIC DISEASES
- Joint immobilization prevents murine osteoarthritis and reveals the highly mechanosensitive nature of protease expression in vivo
- (2012) Annika Burleigh et al. ARTHRITIS AND RHEUMATISM
- Transforming growth factor-alpha induces endothelin receptor A expression in osteoarthritis
- (2012) Shirine E. Usmani et al. JOURNAL OF ORTHOPAEDIC RESEARCH
- CCR2 chemokine receptor signaling mediates pain in experimental osteoarthritis
- (2012) R. E. Miller et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Identification of a central role for complement in osteoarthritis
- (2011) Qian Wang et al. NATURE MEDICINE
- Teriparatide as a Chondroregenerative Therapy for Injury-Induced Osteoarthritis
- (2011) E. R. Sampson et al. Science Translational Medicine
- Phase 1 safety and tolerability study of BMP-7 in symptomatic knee osteoarthritis
- (2010) David J Hunter et al. BMC MUSCULOSKELETAL DISORDERS
- Transcriptional regulation of endochondral ossification by HIF-2α during skeletal growth and osteoarthritis development
- (2010) Taku Saito et al. NATURE MEDICINE
- Hypoxia-inducible factor-2α is a catabolic regulator of osteoarthritic cartilage destruction
- (2010) Siyoung Yang et al. NATURE MEDICINE
- G-protein-coupled receptor independent, immunomodulatory properties of chemokine CXCL9
- (2009) Jiang-Hong Gong et al. CELLULAR IMMUNOLOGY
- Rho/ROCK and MEK/ERK activation by transforming growth factor-α induces articular cartilage degradation
- (2009) C Thomas G Appleton et al. LABORATORY INVESTIGATION
- Modulating hedgehog signaling can attenuate the severity of osteoarthritis
- (2009) Alvin C Lin et al. NATURE MEDICINE
- Syndecan-4 regulates ADAMTS-5 activation and cartilage breakdown in osteoarthritis
- (2009) Frank Echtermeyer et al. NATURE MEDICINE
- Osteoarthritis in patients with anterior cruciate ligament rupture: A review of risk factors
- (2008) Hugues Louboutin et al. KNEE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now